Promise or Peril: COVID-19 mRNA Vaccine Issues Series

The pandemic has ended, but the introduction of the COVID-19 vaccines, which use mRNA technology, signifies the start of a new era in modern medicine. The lagging regulatory framework that the FDA cobbled together specifically for mRNA vaccine approval has set the stage for adverse events related to genetic therapies using this new technology. In this series, we reveal emerging concerns about mRNA injections related to the lipid nanoparticles, spike protein, and vaccine contamination as public documents are released.

Allison Krug is an epidemiologist and program manager with experience leading population health programs. She's the lead author of the first stratified risk-benefit analysis of mRNA vaccination among adolescents and editor for 400+ research manuscripts published in high impact factor, peer-reviewed journals. She's also the founder and CEO of Artemis Biomedical Communications, LLC.
Dr. Ram Duriseti is a clinical associate professor and physician-scientist at Stanford University. He received his MD from the University of Michigan and his medical training and PhD in computational decision modeling from Stanford University. He has practiced in clinical emergency medicine in both community and academic settings for over 22 years.
Xiaoxu Sean Lin is an assistant professor in the Biomedical Science Department at Feitian College in Middletown, New York. He is also a frequent analyst and commentator for Epoch Media Group, VOA, and RFA. He is a veteran who served as a U.S. Army microbiologist and also a member of Committee on the Present Danger: China.
Yuhong Dong
M.D., Ph.D.
Dr. Yuhong Dong, The Epoch Times’ senior medical columnist, is an award-winning senior medical scientific expert in infectious disease and neuroscience who is currently dedicated to researching solid modern scientific evidence of the profound connection between the mind, body, and spirit at the cellular, genetic, and systemic levels.
You May Also Like